Related by context. All words. (Click for frequent words.) 63 amyloid cascade 61 Wischik 60 biologic plausibility 59 prion hypothesis 59 oxysterols 59 underlying pathophysiology 58 hormesis 58 clioquinol 58 non pharmacological interventions 57 CETP inhibition 57 angiogenesis inhibition 57 PPARγ 57 therapeutic modality 57 nongenetic 57 nosology 57 DHEA supplementation 57 telomerase activation 56 erlotinib Tarceva 56 pathogenetic mechanisms 56 Panzem 56 AChE inhibitors 56 amyloid formation 56 Pancreate ™ 55 infantile colic 55 neuroregenerative 55 diabetic kidney 55 hypothesis 55 neuroprotectant 55 pharmacological treatments 55 Maraganore 55 testable hypothesis 55 Hotamisligil 55 synaptic function 55 CB1 antagonists 55 nanobacteria 55 underlying molecular mechanisms 55 neurobiological basis 55 biological plausibility 54 biopsychosocial 54 genetic determinism 54 Eric Siemers 54 aetiological 54 Adjuvant therapy 54 pharmacogenetic testing 54 Bergenstal 54 pharmacological intervention 54 lowering homocysteine 54 pathophysiologic 54 atherosclerotic vascular disease 54 serotonin deficiency 54 teratogenicity 54 atherogenesis 54 biochemical abnormalities 54 BRAF inhibitors 54 mGluR5 inhibition 54 murine models 54 Dendreon Provenge 54 DePinho 54 preclinically 54 Karlseder 54 molecular mimicry 54 orthomolecular medicine 54 Dr. Henschke 54 neuronal dysfunction 54 Anavex #-# 54 RhuDex 54 selenium supplementation 54 neo Darwinism 54 MUC1 * 54 pharmacologic intervention 54 dexpramipexole 54 chemopreventive agents 54 sickle cell hemoglobin 54 pharmacological therapies 53 developmental neurotoxicity 53 mitochondrial disorders 53 antioxidant supplementation 53 beta1 integrin 53 chemopreventive 53 mechanistically 53 chemopreventive agent 53 synthetic lethality 53 Dr. Pestell 53 Alzhemed 53 etiological 53 therapeutic equivalence 53 Dr. Maraganore 53 familial clustering 53 cognitive enhancer 53 autistic enterocolitis 53 chemosensitivity 53 estrogen metabolism 53 pathogenic mechanisms 53 Dr. Bezprozvanny 53 SGS# 53 cholinesterase inhibitors 53 SORL1 gene 53 PARP inhibition 53 multigenic 53 Neo Darwinism 53 neuropsychiatric diseases 53 Lu AA# 53 dementia praecox 53 vertebrate embryos 53 phenotypic expression 53 T#I [002] 53 Cogane 52 SGLT2 inhibitors 52 scientifically testable 52 lowering LDL cholesterol 52 Evolutionary theory 52 Dr. von Herrath 52 CDK inhibitors 52 Lodamin 52 Kaptchuk 52 Dr. Yair Lotan 52 Okunieff 52 spontaneous remission 52 pathological hallmark 52 Myriad Flurizan 52 epigenetic changes 52 dietary interventions 52 CGEN # 52 dietary acrylamide 52 susceptibility gene 52 HSF1 52 protein misfolding diseases 52 α KG 52 SIRT1 activation 52 virotherapy 52 physiologic mechanisms 52 Singh Manoux 52 Onconase 52 neurodiversity 52 riociguat 52 prostate carcinogenesis 52 mGluR4 activation 52 periodontal infection 52 NOD mouse 52 pathophysiological mechanisms 52 CSF biomarkers 52 curative therapy 52 bryostatin 52 autoimmune pancreatitis 52 chromosome translocations 52 impair fertility 52 telomere dysfunction 52 testosterone supplementation 52 zoledronic acid Zometa 52 AZILECT ® 52 CaPre ™ 52 transdifferentiation 52 antiangiogenic therapy 52 Shark cartilage 52 irreducible complexity 52 POM Juice 52 thiopurine 52 pleiotropy 52 protein misfolding 52 Bresalier 52 molecular abnormalities 52 APPROVe study 52 Affinitak 52 transgenic mouse models 52 ontogeny recapitulates phylogeny 52 poststroke depression 52 genomewide association studies 52 anti angiogenic therapy 52 Mechanistic studies 52 Hayflick 52 multi factorial disease 52 flavopiridol 52 motor neuron degeneration 52 Zaven Khachaturian 52 anti CD3 antibody 52 antiplatelet therapies 52 Genetic variation 52 Fatty liver 52 NV1FGF 52 endoxifen 52 abnormal proteins 52 dyskeratosis congenita 52 engineered RAP peptides 52 oral antiplatelet 52 siRNA therapeutics 52 pathophysiological 52 Ravnskov 51 Calorie restriction 51 HMGCR 51 sirtuin activators 51 Cytolin ® 51 causal pathway 51 olaparib 51 stimulate neurogenesis 51 coxibs 51 metabonomics 51 K ras gene 51 Genetic predisposition 51 mTOR inhibition 51 ThGRF 51 Personalised medicine 51 serum biomarkers 51 Rivastigmine 51 sDNA 51 neurobiological underpinnings 51 molecularly defined 51 molecularly targeted therapies 51 macroevolution 51 redox active 51 cediranib 51 Hygiene Hypothesis 51 COX inhibitors 51 prodromal phase 51 Mitochondrial dysfunction 51 Tarvacin 51 dietary modification 51 oncogene addiction 51 testable hypotheses 51 anti angiogenic agents 51 intensive statin therapy 51 Magnesium deficiency 51 LRP5 51 Cyclin E 51 histone code 51 monogenic 51 Chronic pancreatitis 51 CHRNA5 51 biologic pathways 51 Sphingomab 51 APOE genotype 51 multitargeted 51 Ascherio 51 neurobiological mechanisms 51 valvular heart 51 Myerburg 51 empiric 51 unmeasured confounders 51 LRRK2 mutations 51 Bryostatin 51 CALHM1 51 epigenetic regulation 51 CETP inhibitors 51 presymptomatic 51 genetic biomarkers 51 Anacetrapib 51 moxidectin 51 statin medications 51 Tashkin 51 COX enzymes 51 FTIs 51 amyloid plaque formation 51 biphosphonates 51 antioxidant vitamin supplements 51 Kraepelin 51 Boden Albala 51 biopsychosocial model 51 DFMO 51 inherited predisposition 51 Marc Weisskopf 51 PI3K signaling 51 de novo mutations 51 Corus CAD 51 Plutzky 51 metabolomic profiles 51 multicellularity 51 ibudilast 51 late onset hypogonadism 51 CBLC# 51 neo Darwinian evolution 51 Bone marrow transplantation 51 Haptoglobin 51 insoluble plaques 50 antiangiogenic agent 50 comorbid disorders 50 mechanistic explanation 50 MEVACOR 50 OHR/AVR# 50 pathophysiologic mechanisms 50 Sacktor 50 thalidomide Thalomid 50 oral Xeloda 50 mechanistic 50 Prof. Krainer 50 TLE3 50 adoptive immunotherapy 50 ATTR CM 50 Genetic mutation 50 genomically 50 Neuvenge 50 samalizumab 50 multifactorial disease 50 ADDLs 50 MTHFR gene 50 thrifty gene 50 A3 adenosine receptor 50 uncharacterized genes 50 mRNA decay 50 ALI ARDS 50 Autoimmune diseases 50 APOE4 50 SERMs 50 C. pneumoniae 50 Mipomersen 50 discodermolide 50 ApoE4 50 COX 2s 50 assortative mating 50 polygenic 50 indibulin 50 Celgene Revlimid 50 null hypothesis 50 gefitinib Iressa 50 Stapled Peptide 50 dopamine hypothesis 50 neurologic disorder 50 Oncotype 50 medicine EBM 50 molecularly targeted 50 pleiotropic effects 50 multi infarct dementia 50 Wnts 50 N Myc 50 Lpathomab 50 stapled peptides 50 Newton Cheh 50 Xinlay 50 Cognitive impairment 50 DermaVir 50 progranulin protein 50 falsifiability 50 microchimerism 50 predisposing factor 50 antibody mediated 50 iPSC 50 gastrointestinal dysfunction 50 facioscapulohumeral muscular dystrophy 50 delipidation 50 pharmacotherapeutic 50 mitochondrial dysfunction 50 PITX2 methylation 50 Nuedexta 50 Gilead Viread 50 hippocampal function 50 fusion enhancers 50 Sphingomab TM 50 donepezil Aricept 50 neuroinflammatory 50 biochemical mechanisms 50 renal fibrosis 50 insulin analogs 50 antitumour 50 Perforomist ™ Inhalation Solution 50 renoprotective 50 JAK3 inhibitor 50 oscillatory behavior 50 metaanalysis 50 autism spectrum diagnoses 50 epigenetic modification 50 treating neuropathic pain 50 psychotherapies 50 Aviptadil 50 Dr. Groopman 50 epigenetic reprogramming 50 cardiometabolic disorders 50 periprocedural MI 50 p# MAPK 50 Pier Paolo Pandolfi 50 ReN# 50 Dr. Pasinetti 50 cardioprotective effects 50 hereditary predisposition 50 Ets2 50 miR #a [001] 50 HIV protease inhibitors 50 inhibit metastasis 50 MAPK pathway 50 rosiglitazone Avandia 50 pharmacokinetic interactions 50 embodied cognition 50 Symadex 50 residual confounding 50 Novartis Zometa 50 PDE7 inhibitors 50 DHFR 50 proteasome inhibitor 50 statins cholesterol lowering 50 genetic loci 50 epithelial barrier 50 PDE# inhibitors 50 ketogenic diets 50 glutamate signaling 50 probiotic supplementation 50 chemobrain 50 Kaklamani 50 Dr. Aronne 50 Aplidin 50 mTOR inhibitors 50 NITD# 50 BiTE 50 LDL lowering 50 LVNC 50 prognostic indicator 50 Almorexant 50 pharmacological interventions 50 biologically plausible 50 nerve degeneration 50 resolvins 50 Arranon 50 Duesberg 50 amyloid protein plaques 50 KRAS oncogene 50 DLC1 50 neurodegeneration 49 debilitating neurodegenerative disorder 49 metabolic alterations 49 Genetic variants 49 K ras mutations 49 amyloid pathology 49 Curaxin 49 antidepressant efficacy 49 causative genes 49 D mab 49 aetiology 49 genetic polymorphism 49 Rasagiline 49 BARD1 49 Ataluren 49 neuroAIDS 49 K ras mutation 49 mitochondrial defects 49 TGFBR1 * 6A 49 Dr. Ivashkiv 49 therapies 49 Pigliucci 49 AFFiRiS 49 Rilutek 49 Bartzokis 49 GABRA2 gene 49 Preimplantation Factor 49 anti angiogenesis 49 KRAS variant 49 neuroprotective therapies 49 elevated CRP 49 DNA demethylation 49 FBPase 49 Dr. Von Hoff 49 Kuritzkes 49 lupus multiple sclerosis 49 H. pylori eradication 49 MyVax 49 KRAS mutation 49 anticancer therapy 49 Comparative effectiveness 49 Kevetrin ™ 49 Vernakalant 49 inherit predisposition 49 PTEN mutations 49 biomarker identification 49 sociological theories 49 plasma pharmacokinetics 49 spontaneous regression 49 berberine 49 KRAS mutation status 49 pioglitazone Actos 49 LY# [003] 49 Antioxidant supplements 49 ovarian hormones 49 TCF#L# gene 49 astressin B 49 KRAS status 49 pharmacological approaches 49 therapeutically useful 49 Ampakine 49 Thase 49 Molly Wagster 49 ACAT2 49 endophenotypes 49 Optimata 49 synovial cells 49 Kaplitt 49 benfotiamine 49 Sodroski 49 ONCONASE R 49 Safinamide 49 bioequivalency 49 Pazdur 49 putative biomarkers 49 antidepressive 49 EGFR signaling 49 ALK inhibitors 49 histone deacetylase inhibitors 49 proliferative disorders 49 epigenetic mechanisms 49 ADAGIO study 49 genes CYP#C# 49 sphingolipid 49 pharmacologic treatments 49 etiologic 49 nanoviricide 49 stimulant ADHD 49 ovarian suppression 49 ImmunoVEX HSV2 49 Randomized trials 49 ganaxolone 49 Ashwell receptor 49 Valdoxan 49 disregulation 49 leaky gut 49 triterpenoids 49 molecular biomarkers 49 amyloid peptide 49 cardiac glycosides 49 beta amyloid plaques 49 Stanley Fahn 49 Hypotheses 49 Nuvigil armodafinil 49 Kattlove 49 muscular dystrophies 49 protein conformation 49 Dr. Borlongan 49 physicochemical 49 fibrotic disease 49 pharmacogenetic tests 49 apoptosis induced 49 immuno suppressive 49 mutated protein 49 tecarfarin 49 prodynorphin 49 pharmacogenetic 49 FGFs 49 Mikovits 49 LaFerla 49 Pi Sunyer 49 alpha syn 49 Mendelian genetics 49 Ken Kornman 49 anti angiogenic drugs 49 amyloid plaque 49 neuro degenerative diseases 49 thyroid dysfunction 49 Szent Gyorgyi 49 gastrointestinal absorption 49 Tocosol 49 Chlamydia psittaci 49 statistical correlations 49 nonpharmacologic 49 heritable variation 49 genetic polymorphisms 49 myeloproliferative neoplasms MPNs 49 Wyss Coray 49 subgroup analyzes 49 String theory 49 adeno associated viruses 49 Relapsing remitting MS 49 cyto 49 Methotrexate MTX 49 rheumatic disorders 49 atherosclerosis regression 49 monoclonal antibody therapeutics 49 JoAnn Manson 49 Vanlev 49 Temsirolimus 49 Alzheimer disease pathology 49 Byetta LAR 49 PVS diagnosis 49 BNC# 49 HDAC3 49 Trandolapril 49 RhuDex ® 49 humanized monoclonal antibodies 49 gepirone ER 49 antithrombotic agents 49 lethal mutagenesis 49 Cinquil 49 adult neurogenesis 49 nocebo effect 49 hypotheses 49 melatonin receptor 49 Mechanistically 49 PARP inhibitors 49 glitazones 49 Leydig cell 49 antiarrhythmic 49 neuro developmental disorders 49 protein homeostasis 49 epigenetic therapies 49 Cardiotoxicity 49 VKORC1 49 biochemical imbalances 49 vertebral subluxation 49 circadian rhythm disorders 49 Fc gamma receptor 49 vascular disrupting agents 49 evolvability 48 chronic hepatitis cirrhosis 48 Shlipak 48 neuropsychiatric symptoms 48 biologic therapeutics 48 chromosomal instability 48 tumor subtype 48 Ele Ferrannini 48 biomarker assay 48 isradipine 48 Vidaza azacitidine 48 Non inferiority 48 OX1 48 mtDNA mutations 48 AL amyloidosis 48 protein beta catenin 48 solanezumab 48 gamma secretase inhibitor 48 prion gene 48 Alzheimers disease 48 pathogenetic 48 S. maltophilia 48 methodological naturalism 48 suppressor gene 48 follicular adenoma 48 Kristine Yaffe MD 48 alpha synuclein gene 48 nocebo 48 neuroglobin 48 Zolopa 48 antiangiogenesis 48 modifier genes 48 genomic variants 48 #F FDG PET 48 TLR9 agonists 48 agonism 48 psychobiological 48 Pericak Vance 48 Osteopenia 48 GPx 48 lung cancer chemoprevention 48 etiologic factors 48 antiviral therapies 48 empirical observation 48 Velculescu 48 Genentech Herceptin 48 PTK# 48 Marambaud 48 Xanafide 48 uncurable 48 vivo validation 48 gut microbiota 48 fermentable carbohydrates 48 JAK3 48 epigenetic markers 48 Rasenick 48 GPIHBP1 48 lipid particle 48 Tolamba 48 HLA G 48 embryological 48 Histalean 48 DARPP 48 scientifically invalid 48 SPARCL 48 mecamylamine 48 genetic modifiers 48 oral anticoagulation 48 fluoroquinolone resistance 48 folate supplementation 48 Helicobacter pylori infection 48 CYP#C# gene 48 Fingolimod 48 Chlamydia pneumoniae 48 FGFR2 gene 48 nondemented 48 cardiac fibrosis 48 tumorigenicity 48 Einstein relativity theory 48 hepatotoxic 48 AGW theory 48 MSH2 48 excitotoxicity 48 untestable 48 Bleomycin 48 GFT# 48 β blockers 48 untreatable diseases 48 telomere biology 48 Carl Dieffenbach 48 CNTNAP2 gene 48 Deforolimus 48 Neurodegenerative diseases 48 reperfusion injury 48 pure fructose 48 hematopoietic cancers 48 immunotoxin 48 proteasome inhibitors 48 ALK gene 48 histone methylation 48 Ruschitzka 48 torcetrapib atorvastatin 48 KIBRA 48 mitochondrial diseases 48 CYP #A# 48 N glycan 48 histone deacetylase HDAC 48 coevolution 48 APOE e4 48 Tschöp 48 Micro RNAs 48 liver metastasis 48 Neugut 48 baldness cure 48 podocyte 48 choroidal vasculopathy 48 diagnostic biomarker 48 CYP#A# gene 48 Alzheimer disease pathogenesis 48 multigene 48 Cognitive dysfunction 48 cybrids 48 prognostic marker 48 genetic determinants 48 hermaphroditism 48 mutancy 48 aneuploidy 48 pharmacoeconomic 48 histologic diagnosis 48 Ariad 48 epistasis 48 Dr. Kaplitt 48 Klotho 48 Ontak 48 Proteostasis Network 48 alpha fetoprotein AFP 48 synergistic combinations 48 gene locus 48 Abiraterone acetate 48 AE# vaccine 48 serotonin imbalance 48 chimerism 48 Bucindolol 48 canagliflozin 48 Bairey Merz 48 immuno oncology 48 Viread tenofovir 48 DeKosky 48 ADME properties 48 familial aggregation 48 systemic RNAi 48 Freudian psychoanalysis 48 anti TNFa 48 orally dosed 48 PYY #-# 48 immune reconstitution syndrome 48 Inhaled insulin 48 nomograms 48 Paleolithic diet 48 exon skipping 48 ABL1 48 epigenetic inheritance 48 MitoQ 48 peptidic 48 #HT#A receptor 48 verified experimentally 48 Personalized medicine 48 Fanconi syndrome 48 Taranabant 48 quinacrine 48 Varki 48 Tarvacin Anti Viral 48 GSK# [002] 48 alternans 48 Hsp# inhibition 48 Melov 48 Youdim 48 Ateronon 48 LRRK2 mutation 48 PTEN protein 48 heritable diseases 48 arterial calcification 48 Piomelli 48 epithelial tumors 48 imexon 48 ATL# [001] 48 staphylococcal vaccine 48 PROCHYMAL 48 surrogate endpoint 48 genetic susceptibilities 48 cyclophilin inhibitors 48 Riluzole 48 amyloid accumulation 48 Guanilib 48 EGFR inhibition 48 molecular chaperone regulator 48 Novartis AG Gleevec 48 antiobesity 48 proteomic technologies 48 sorafenib Nexavar 48 molecular pathways 48 Chronic Lyme disease 48 monoclonal gammopathy 48 surrogate endpoints 48 LY# [002] 48 antiresorptive 48 postprandial glycemia 48 carbohydrate restriction 48 Caloric restriction 48 tau mutation 48 EBV infection 48 Fulvestrant 48 Pfizer torcetrapib 48 EGFR pathway 47 LSI #P 47 overdiagnose 47 Psoraxine R 47 ELISPOT assay 47 teplizumab 47 behavioral disinhibition 47 hypochondriasis 47 psychopharmacological 47 tropism 47 pharmacokinetic characteristics 47 Heisenberg principle 47 HCV protease inhibitors 47 Teriflunomide 47 Doribax 47 Cabilly patent 47 adjuvant systemic 47 colon carcinogenesis 47 therapeutic regimens 47 intravenous cyclophosphamide 47 ecotherapy 47 ixabepilone 47 multifactorial 47 Angiolix 47 lipoprotein metabolism 47 prognostic biomarkers 47 observational studies 47 OnDose TM 47 anosognosia 47 neurochemistry 47 micro RNAs 47 antidepression 47 epidemiologically 47 MAGE A3 ASCI 47 selective modulator 47 STK# [002] 47 Dr. Christer Hoglund 47 spongiform encephalopathies 47 Redei 47 Rheos System 47 intensive lipid lowering 47 MLL2 47 Gingko biloba 47 Campos Outcalt 47 Capesaris 47 Abacavir 47 Michael Kaplitt Parkinson 47 PROSTVAC TM 47 APOE ε4 47 Pathological gambling 47 mGluR5 antagonists 47 DCVax R 47 rituximab Rituxan 47 neurocognitive deficits 47 TGFBR1 47 artifactual 47 MMP inhibitors 47 multivitamin supplementation 47 Sipuleucel T 47 surrogate markers 47 SGLT 2 47 Dr. Sharonne Hayes 47 nucleosome positioning 47 Kenneth S. Kendler 47 pleiotropic 47 subclinical atherosclerosis 47 Alzheimer pathology 47 hyperinsulinemia 47 Cytolin R 47 methodological limitations 47 G. biloba 47 renal denervation 47 SureGene 47 Darwinian evolutionary theory 47 proteasome inhibition 47 adjuvant trastuzumab 47 LIS1 47 ApoE gene 47 cAMP signaling 47 BioLeap 47 tigecycline 47 CXCR7 47 insulin resistance syndrome 47 PathFinderTG 47 differential gene expression 47 retrovirus XMRV 47 diabesity 47 vascular thrombosis 47 chronic Lyme 47 mda 7 47 PDGF alpha receptor 47 XMRV infection 47 alkalosis 47 urinary biomarkers 47 Serebruany 47 Src kinase 47 causation 47 Kenneth Mukamal 47 Alzheimer Disease AD 47 metabolic dysfunctions 47 intestinal microflora 47 Fenretinide 47 Dr. Tobias Kurth 47 cMET 47 diagnostic biomarkers 47 hedgehog pathway 47 systemic mastocytosis 47 imatinib Gleevec 47 rBChE 47 Tom Misteli 47 anti androgens 47 Geoffrey Porges 47 XmAb# 47 Zipursky 47 anti angiogenic agent 47 LHRH 47 Parkinson disease neurodegenerative disorder 47 rheumatoid arthritis lupus 47 epigenetic silencing 47 causal relation 47 oligodendroglial progenitor cells 47 IDH mutations 47 cordycepin 47 Gleevec imatinib mesylate 47 neuropathologic 47 phenotypic variability 47 Gurbel 47 Adesman 47 Zolinza 47 epigenetic modifications 47 chaperone proteins 47 incommensurability 47 Vertex hepatitis C 47 Vitamin D supplementation 47 Cotsarelis 47 Getzenberg 47 diagnosing autism 47 vascular cognitive impairment 47 immunotherapeutic vaccine 47 prognostic indicators 47 antiphospholipid antibodies 47 radezolid 47 Factor Xa inhibitors 47 adrenal fatigue 47 correlational 47 clinically insignificant 47 Geiers 47 bezafibrate 47 Zlokovic 47 epigenetic therapeutics 47 EGS# 47 HIV tropism 47 circadian rhythmicity 47 Weese Mayer 47 Evolutionary biology 47 Matthew Meyerson 47 Shaywitz 47 progressive neurodegenerative disorder 47 COMMD1 47 2DG 47 confounder 47 ARF1 47 drugable targets 47 Valproic acid 47 TRIM5 47 Sackner Bernstein 47 oxidative stress induction 47 Genentech Biogen 47 ranibizumab Lucentis 47 genomewide 47 multiple sclerosis lupus 47 ReoPro 47 monoclonal antibody therapies 47 conserved sequences 47 atherothrombotic 47 ischemic preconditioning 47 therapeutic armamentarium 47 Olaparib 47 PGxPredict tests 47 sporadic ALS 47 Scorpion venom 47 prolongs survival 47 pharmacogenetics 47 Jon Kar Zubieta 47 HPCGG 47 embryonic stem cells ESCs 47 D cycloserine 47 Soffritti 47 evo devo 47 LV dysfunction 47 Helicobacter pylori H. pylori 47 peginterferon alpha 47 Milk thistle